Dermatomyositis — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Anti-TIF1γ myositis antibody
The best answer is “Anti-TIF1γ myositis antibody”. Dermatomyositis combines characteristic cutaneous signs with inflammatory myopathy; antibody phenotype helps estimate malignancy and interstitial-lung-disease risk but must be interpreted with the clinical picture. The alternatives “Anti-Mi-2 antibody”, “Anti-MDA5 antibody”, “Anti-Jo-1 antibody”, “Anti-SRP antibody” are clinically adjacent possibilities, but they do not fit the defining morphology, distribution, histopathology, risk signal or management sequence in this stem.
Reference: BAD dermatomyositis information: https://www.bad.org.uk/pils/dermatomyositis